Literature DB >> 26231114

Protective Effects of Antioxidant Peptide SS-31 Against Multiple Organ Dysfunctions During Endotoxemia.

Guoming Li1, Jing Wu2, Renqi Li2, Dong Yuan1, Yunxia Fan1, Jianjun Yang2, Muhuo Ji3, Sihai Zhu4.   

Abstract

Oxidative stress causes mitochondrial impairment, the failure of energy production, and consequent organ dysfunctions. The aim of the present study was to investigate the potential therapeutic effects of mitochondrial antioxidant SS-31 on sepsis-induced organ dysfunctions and to explore the possible mechanism. Sepsis was induced by cecal ligation and puncture. Immediately and at 5 h after the operation, SS-31 (5 mg/kg) or vehicle was administered intraperitoneally. The levels of organ dysfunctions, malondialdehyde, superoxide dismutase, proinflammatory cytokines, pulmonary wet-to-dry weight ratio, myeloperoxidase activity, histological scores, nuclear factor kappa B p65, inducible nitric oxide synthase, reactive oxygen species, adenosine triphosphate, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells were assessed at the indicated time points. The 7-day survival rate was estimated by the Kaplan-Meier method. In the present study, SS-31 treatment significantly improved sepsis-induced organ dysfunctions as evidenced by decreased histological scores, increased arterial partial oxygen tension, and deceased serum alanine aminotransferase, urea nitrogen, and creatinine levels, which was accompanied by decreased levels of malondialdehyde, tumor necrosis factor-alpha, pulmonary myeloperoxidase activity, nuclear factor kappa B p65, inducible nitric oxide synthase, reactive oxygen species, and TUNEL-positive cells. In conclusion, our data suggested that the protective effects of SS-31 on sepsis-induced organ dysfunctions were associated with the inhibition of proinflammatory cytokines, oxidative stress, and apoptosis.

Entities:  

Keywords:  apoptosis; inflammation; mitochondria; oxidative stress; sepsis

Mesh:

Substances:

Year:  2016        PMID: 26231114     DOI: 10.1007/s10753-015-0222-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  27 in total

1.  Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation.

Authors:  K Mertens; D A Lowes; N R Webster; J Talib; L Hall; M J Davies; J H Beattie; H F Galley
Journal:  Br J Anaesth       Date:  2015-03-31       Impact factor: 9.166

2.  Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial.

Authors:  David R Janz; Julie A Bastarache; Todd W Rice; Gordon R Bernard; Melissa A Warren; Nancy Wickersham; Gillian Sills; John A Oates; L Jackson Roberts; Lorraine B Ware
Journal:  Crit Care Med       Date:  2015-03       Impact factor: 7.598

3.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

4.  Ghrelin attenuates sepsis-associated acute lung injury oxidative stress in rats.

Authors:  Mian Zeng; Wanmei He; Lijun Li; Bin Li; Liang Luo; Xubin Huang; Kaipan Guan; Weiling Chen
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

5.  The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

Authors:  Alexander V Birk; Shaoyi Liu; Yi Soong; William Mills; Pradeep Singh; J David Warren; Surya V Seshan; Joel D Pardee; Hazel H Szeto
Journal:  J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 10.121

6.  Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice.

Authors:  Michael P Siegel; Shane E Kruse; Justin M Percival; Jorming Goh; Collin C White; Heather C Hopkins; Terrance J Kavanagh; Hazel H Szeto; Peter S Rabinovitch; David J Marcinek
Journal:  Aging Cell       Date:  2013-06-11       Impact factor: 9.304

7.  Effects of hydrogen-rich saline treatment on polymicrobial sepsis.

Authors:  Guo-Min Li; Mu-Huo Ji; Xue-Jun Sun; Qiu-Ting Zeng; Mi Tian; Yun-Xia Fan; Wei-Yan Li; Ning Li; Jian-Jun Yang
Journal:  J Surg Res       Date:  2012-07-07       Impact factor: 2.192

8.  Mitochondrial anti-oxidant protects IEX-1 deficient mice from organ damage during endotoxemia.

Authors:  Haley Ramsey; Mei X Wu
Journal:  Int Immunopharmacol       Date:  2014-12       Impact factor: 4.932

Review 9.  The role of mitochondrial dysfunction in sepsis-induced multi-organ failure.

Authors:  Mervyn Singer
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

10.  Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis.

Authors:  D A Lowes; N R Webster; M P Murphy; H F Galley
Journal:  Br J Anaesth       Date:  2013-02-04       Impact factor: 9.166

View more
  10 in total

Review 1.  Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.

Authors:  Hazel H Szeto
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

2.  Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.

Authors:  Hazel H Szeto; Shaoyi Liu; Yi Soong; Surya V Seshan; Leona Cohen-Gould; Viacheslav Manichev; Leonard C Feldman; Torgny Gustafsson
Journal:  J Am Soc Nephrol       Date:  2016-11-23       Impact factor: 10.121

3.  Increased Survival Time With SS-31 After Prolonged Cardiac Arrest in Rats.

Authors:  Wei Zhang; Jonathan Tam; Koichiro Shinozaki; Tai Yin; Joshua W Lampe; Lance B Becker; Junhwan Kim
Journal:  Heart Lung Circ       Date:  2018-02-07       Impact factor: 2.975

Review 4.  Mitochondria in Sepsis-Induced AKI.

Authors:  Jian Sun; Jingxiao Zhang; Jiakun Tian; Grazia Maria Virzì; Kumar Digvijay; Laura Cueto; Yongjie Yin; Mitchell H Rosner; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2019-05-10       Impact factor: 10.121

5.  The Pathophysiology of Sepsis-Associated AKI.

Authors:  Shuhei Kuwabara; Eibhlin Goggins; Mark D Okusa
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-28       Impact factor: 10.614

Review 6.  Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches.

Authors:  Divya Bhatia; Allyson Capili; Mary E Choi
Journal:  Kidney Res Clin Pract       Date:  2020-09-30

Review 7.  SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease.

Authors:  Yuexin Zhu; Manyu Luo; Xue Bai; Jicui Li; Ping Nie; Bing Li; Ping Luo
Journal:  Oxid Med Cell Longev       Date:  2022-06-06       Impact factor: 7.310

Review 8.  Oxidative-Nitrosative Stress and Myocardial Dysfunctions in Sepsis: Evidence from the Literature and Postmortem Observations.

Authors:  M Neri; I Riezzo; C Pomara; S Schiavone; E Turillazzi
Journal:  Mediators Inflamm       Date:  2016-05-04       Impact factor: 4.711

9.  Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.

Authors:  Vladimir Mayorov; Peter Uchakin; Venkataraman Amarnath; Alexander V Panov; Christy C Bridges; Roman Uzhachenko; Bill Zackert; Christy S Moore; Sean Davies; Anna Dikalova; Sergey Dikalov
Journal:  Redox Biol       Date:  2019-08-14       Impact factor: 11.799

Review 10.  Protective Effect of Mitochondria-Targeted Antioxidants against Inflammatory Response to Lipopolysaccharide Challenge: A Review.

Authors:  Ekaterina M Fock; Rimma G Parnova
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.